Today, March 13, 2025, Biovica International AB (the "Company") disclosed its financial report for the period November 2024 - January 2025 with information on the Company's financial situation.
The rules of Nasdaq First North Growth Market state that an issuer can be given observation status if there is material adverse uncertainty in respect of the issuer's financial position.
With reference to the above, Nasdaq Stockholm AB decides that the shares in Biovica International AB (BIOVIC B, ISIN code SE0008613731, order book ID 135531) shall be given observation status.
For further information about this exchange notice please contact Enforcement & Investigations, telephone +46 8 405 70 50.
Nasdaq Stockholm AB
© 2025 GlobeNewswire
